Elevate Compliance, Data Capture & Reporting for the Drug Supply Chain Security Act (DSCSA)

With DSCSA requirements in effect, MedPro helps pharmaceutical manufacturers, wholesale distributors and third-party logistics providers support compliant shipment reporting through accurate license validation, SLN-GLN data matching and ongoing data stewardship across the supply chain.

Book a Demo

DSCSA Requirements

Pharmaceutical manufacturers, wholesale distributors and third-party logistics providers are now required to report the location data of their product shipments as they move through the supply chain under the updated DSCSA (Drug Supply Chain Security Act) requirements.

To meet these requirements, the industry has adopted Global Location Numbers (GLNs) as the standard for reporting location data – layering in GLN capture with State License Number (SLN) review as part of their comprehensive Authorized Trading Partner (ATP) validation process. Building and implementing data governance strategies adopt for linking and validating GLNs and SLNs is essential to remain complaint.

Without proper preparation, your organization may face:

Disruption in your supply-chain management
Increased requirements from major supply chain players for both SLN and GLN data within EPCIS messages
Manual review and linking data
Potential shipping delays and non-compliance due to outdated or error prone SLN-GLN data
Limitations with existing healthcare data vendors who may not be equipped to validate SLN-GLN data
Significant delays in compliantly shipping products to patients in need

How MedPro Can Help

Organizations need a reliable way to validate both State License Numbers (SLNs) and Global Location Numbers (GLNs) as part of the Authorized Trading Partner (ATP) verification process. GLNs now play a critical role in identifying ship-to locations, while licensure remains essential for confirming trading partner status. Together, these data points support more complete, accurate and compliant shipment reporting across the drug supply chain.

MedProID supports this process with accurate and comprehensive HCP and HCO identifying data, automated SLN license validation and proactive update processes. As DSCSA requirements have expanded to include GLN verification, MedPro helps organizations connect these evolving data sources so teams can reduce manual review, strengthen data quality and maintain greater confidence in their compliance workflows.

MedPro provides pre-verified GLN-SLN relationships with serialized GLNs (sGLNs) to fulfill ATP validation requirements. Our industry-first SLN-GLN crosswalk includes more than 500,000 matched ATP SLN-GLN associations and growing, including ATP license types across pharmacies, clinics, hospitals, wholesalers and distributors.

Validate SLN and GLN data as part of ATP verification
Cross-reference current ATP data and append missing GLN information from the official GLN register
Support one-time data projects and ongoing ATP license and GLN updates
Reduce manual review and linking of SLN-GLN data
Help resolve missing GLN information through enhanced verification and ATP outreach
Strengthen the data foundation behind compliant shipment reporting

Book a Demo

Customer Success Story

MedPro Empowered One of the Nation’s Largest Wholesale Distributors to Ensure Compliance Ahead of DSCSA Deadline

“There is a lot of complexity to how customers get GLNs, the regulations, and how they’re enforced. When it comes down to it, I don’t think anyone knows the GLN landscape better than MedPro. The data is widely complicated and we’ve partnered with MedPro to address together to ensure a smooth transition to DSCSA.”

– SVP, Customer and Sales Support

MedPro Systems’ industry-first SLN-GLN crosswalk, combined with premier customer support and call center, has enabled this major distributor to efficiently ship products to their customer-base without interruption, all while preparing for the upcoming DSCSA deadline.

With requirements from DSCSA tightening, this organization needed to capture GLN information from their customers. Many of those customers were unaware of the new requirements, and collecting GLNs manually was proving inefficient and resource-intensive and sometimes with unsuccessful results.

MedPro Systems implemented a multi-pronged approach. Customer files were automatically processed in BulkID, where MedPro’s SLN-GLNs crosswalk appended known GLNs. For records missing GLN data, MedPro developed a streamlined, automated process that educates customers on the requirements and captures GLN data directly.

When needed, MedPro’s Information Verification Call Center follows up with targeted calls to their customers to secure the remaining data.

With MedPro’s comprehensive and adaptable process, and world-class HCP data, this leading distributor was able to reduce their most challenging records by 70%, avoiding product shipment delays and protected revenue.

MedPro raised awareness among their customers who were unfamiliar with this new regulation and ensured future GLN compliance. This MedPro customer now has the data and processes in place to continue shipping products compliantly and efficiently ahead of the DSCSA deadline.

See How MedPro Can Give You an Efficient, Scalable Foundation for Compliance

Book a demo of our best-in-class license validation platform and enjoy a complimentary two-week trial. Plus, we’ll validate any size test file against our dataset, for a no-cost, no obligation data review!